PPARD and squamous cell carcinoma: PPARβ/δ-knockout animals were more susceptible to skin carcinogenesis as their wildtype counterparts and PPARβ/δ agonists inhibited keratinocyte proliferation [104], as well as proliferation in a human squamous-cell carcinoma cell line [105].